Contact

©2018 by WINBrand.

CONTACT US

Thanks for your interest in our research. Get in touch with us for any questions or comments regarding our work and publications. We’d love to hear from you.

SIGMA PM5_edited_edited.png

SIGMA PM-5 NANOBUBBLE GENERATOR

Molecule

PUBLICATIONS

Scientist in the Lab

COLLABOLATION

CANCER TREATMENT

Development of single-nanometer sized ultrafine oxygen bubbles to overcome hypoxia-induced radiation resistance via suppression of hypoxia-inducible factor- 1 α. Iijima M. Gombodorj N. Tachibana Y. Tachibana K. Yokobori T. Nakano T. Asao T. Kuwahara R. Aoyama K. Yasuda H. Kelly M. Kuwano H. and Yamanouchi D. International Journal of Oncology.  2018 Jan 18. doi: 10.3892/ijo.2018.4248. [Epub ahead of print]

INFECTION TREATMENT

COMING SOON

CARDIOVASCULAR DISEASE

COMING SOON

OUR RESEARCH

Microscope

WINBRAND

NANOBUBBLE RESEARCH AND DEVELOPMENT INSTITUTE

The main goal of our Research and Development Institute is to understand the characteristics of nanobubble and its application to various human disease process. Our institution is providing a platform for nanobubble research ranging from bench top cells based assay to clinical studies. We are currently collaborating with many national and international academic institutions. We use a combination of approaches and technologies that we have developed for use in our studies. Learn more about our research and areas of study below.